You do realise this is a junior biotech company?? These trials take a long time and a lot of money to conclude. They have announced results from an as yet to complete phase 1 study and preclinical studies. Throw in some real world examples of interesting, but not definitive results from people being treated and this is an interesting high risk company. Very early days!
This information is publicly announced to market. Recce would be committing securities fraud if it wasn't backed up with data.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $86.51M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 29.0¢ | $37.22K | 127.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8471 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 17050 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |